GSEA analysis revealed the activation of cancer cell proliferation, EMT and tumour metastasis in the SPP1/HMOX1 overexpression group compared to the control group, indicating potential regulatory roles in glioma progression. This evidence concerns the gene SPP1 and central nervous system cancer.